Cutting edge early risk detection tests and preventive medicine have become the privilege of the wealthy. Dr. James Ehrlich, a pioneer in cardiovascular risk assessment, hopes to change that with his new Identify Disease in Advance Foundation, which will bring state-of-the-art preventive medicine to people who can least afford it but would most benefit from it.
Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.
"From diabetes to hypertension, cancer to drug addiction, stroke to intestinal motility, memory and learning disorders to septic shock, sunburn to anorexia, male impotence to tuberculosis, there is probably no pathological condition where nitric oxide does not play an important role."
Chronic fatigue syndrome (CFS), one of the most vexing conditions for patients and doctors alike, reflects a state of oxygen toxicity, and management of oxidative stress appears to be a key to reversing the fatigue, pain, and neuropsychological complaints associated with this disorder, says Paul R. Cheney, MD, PhD, a pioneer in the clinical research of CFS.
A new vanguard of "metabolic" cardiologists contends that cholesterol elevation has been overstated as a cause of heart disease, and that physicians should pay more attention to the heart muscle itself. A quartet of nutrients magnesium, co-enzyme Q10, L-carnitine, and D-ribose can profoundly improve the heart's pumping ability and reduce risk of death, even in very ill patients.
Readers of Holistic Primary Care are giving a big boost to the Trial to Assess Chelation Therapy (TACT), a landmark NIH study to determine whether chelation therapy can prevent heart attacks. After reading about the ongoing trial in our Spring 2008 edition, 17 physician readers called the study's headquarters in Miami Beach, seeking to enroll their clinics as study sites.